Concepedia

Helen Aylott

HA

3

Publications

121

Citations

3

H-Index

2018

Active since

Affiliations

GlaxoSmithKline (Germany)(Current)

Helen Aylott is an author at GlaxoSmithKline (Germany) specializing in organic chemistry, natural sciences, and biochemistry.

ORCID

Top concepts

Publications per year

2018–2021

3

Publications

3

The Optimization of a Novel, Weak Bromo and Extra Terminal Domain (BET) Bromodomain Fragment Ligand to a Potent and Selective Second Bromodomain (BD2) Inhibitor

Jonathan T. Seal, Stephen J. Atkinson, Helen Aylott et al. · Journal of Medicinal Chemistry · 2020 · 63 citations · Full text

Development of a Large-Scale Copper(I)/TEMPO-Catalyzed Aerobic Alcohol Oxidation for the Synthesis of LSD1 Inhibitor GSK2879552

Augustine Ochen, Robert Whitten, Helen Aylott et al. · Organometallics · 2018 · 30 citations

, , +18

Template-Hopping Approach Leads to Potent, Selective, and Highly Soluble Bromo and Extraterminal Domain (BET) Second Bromodomain (BD2) Inhibitors

Helen Aylott, Stephen J. Atkinson, Paul Bamborough et al. · Journal of Medicinal Chemistry · 2021 · 28 citations · Full text

Rows per page

1–3 of 3